Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

Autor:	Kumar Rai, Ganesh, Saluja, Tarun *, Chaudhary, Shipra, Tamrakar, Dipesh, Kanodia, Piush, Giri, Bishnu Rath, Shrestha, Rajeev, Uranw, Surendra, Kim, Deok Ryun, Yang, Jae Seung, Park, Il-Yeon, Kyung, Seung-Eun, Vemula, Sridhar, Reddy E, Jagadeesh, Kim, Bomi, Gupta, Birendra Prasad, Jo, Sue Kyoung, Ryu, Ji Hwa, Park, Ho Keun, Shin, Jong Hoon, Lee, Yoonyeong, Kim, Hun, Kim, Jerome H, Mojares, Zenaida Reynoso, Wartel, T Anh, Sahastrabuddhe, Sushant
Zdroj:	In The Lancet Infectious Diseases April 2022 22(4):529-540
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu